Pharma & Healthcare
Insomnia Medication - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
- Sep 18, 24
- ID: 552189
- Pages: 130
- Figures: 264
- Views: 1
The global market for Insomnia Medication was estimated to be worth US$ 2921.6 million in 2023 and is forecast to a readjusted size of US$ 3710.3 million by 2030 with a CAGR of 3.4% during the forecast period 2024-2030
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Insomnia Medication, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Insomnia Medication by region & country, by Type, and by Application.
The Insomnia Medication market size, estimations, and forecasts are provided in terms of sales volume (K Pcs) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Insomnia Medication.
Market Segmentation
By Company
Eisai
Merck
Pfizer
Sanofi
Takeda
Vanda Pharmaceuticals
Astellas
Dainippon Sumitomo
ECR Pharmaceuticals (Valeant)
Flynn Pharma
Johnson & Johnson
Meda
Somnus Therapeutics
Purdue Pharma
Neurim
Minerva Neurosciences
Pernix Therapeutics
SkyePharma
Paratek Pharmaceuticals
Segment by Type:
Nonbenzodiazepine Receptor Agonists
Benzodiazepine Receptor Agonists
The Selective Melatonin Receptor Agonist Ramelteon
Sedating Antidepressants
Segment by Application
Adults
Kids
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Insomnia Medication manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Insomnia Medication in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Insomnia Medication in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Insomnia Medication, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Insomnia Medication by region & country, by Type, and by Application.
The Insomnia Medication market size, estimations, and forecasts are provided in terms of sales volume (K Pcs) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Insomnia Medication.
Market Segmentation
By Company
Eisai
Merck
Pfizer
Sanofi
Takeda
Vanda Pharmaceuticals
Astellas
Dainippon Sumitomo
ECR Pharmaceuticals (Valeant)
Flynn Pharma
Johnson & Johnson
Meda
Somnus Therapeutics
Purdue Pharma
Neurim
Minerva Neurosciences
Pernix Therapeutics
SkyePharma
Paratek Pharmaceuticals
Segment by Type:
Nonbenzodiazepine Receptor Agonists
Benzodiazepine Receptor Agonists
The Selective Melatonin Receptor Agonist Ramelteon
Sedating Antidepressants
Segment by Application
Adults
Kids
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Insomnia Medication manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Insomnia Medication in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Insomnia Medication in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
1 Market Overview
1.1 Insomnia Medication Product Introduction
1.2 Global Insomnia Medication Market Size Forecast
1.2.1 Global Insomnia Medication Sales Value (2019-2030)
1.2.2 Global Insomnia Medication Sales Volume (2019-2030)
1.2.3 Global Insomnia Medication Sales Price (2019-2030)
1.3 Insomnia Medication Market Trends & Drivers
1.3.1 Insomnia Medication Industry Trends
1.3.2 Insomnia Medication Market Drivers & Opportunity
1.3.3 Insomnia Medication Market Challenges
1.3.4 Insomnia Medication Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Insomnia Medication Players Revenue Ranking (2023)
2.2 Global Insomnia Medication Revenue by Company (2019-2024)
2.3 Global Insomnia Medication Players Sales Volume Ranking (2023)
2.4 Global Insomnia Medication Sales Volume by Company Players (2019-2024)
2.5 Global Insomnia Medication Average Price by Company (2019-2024)
2.6 Key Manufacturers Insomnia Medication Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Insomnia Medication Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Insomnia Medication
2.9 Insomnia Medication Market Competitive Analysis
2.9.1 Insomnia Medication Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Insomnia Medication Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Insomnia Medication as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Nonbenzodiazepine Receptor Agonists
3.1.2 Benzodiazepine Receptor Agonists
3.1.3 The Selective Melatonin Receptor Agonist Ramelteon
3.1.4 Sedating Antidepressants
3.2 Global Insomnia Medication Sales Value by Type
3.2.1 Global Insomnia Medication Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Insomnia Medication Sales Value, by Type (2019-2030)
3.2.3 Global Insomnia Medication Sales Value, by Type (%) (2019-2030)
3.3 Global Insomnia Medication Sales Volume by Type
3.3.1 Global Insomnia Medication Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Insomnia Medication Sales Volume, by Type (2019-2030)
3.3.3 Global Insomnia Medication Sales Volume, by Type (%) (2019-2030)
3.4 Global Insomnia Medication Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Adults
4.1.2 Kids
4.2 Global Insomnia Medication Sales Value by Application
4.2.1 Global Insomnia Medication Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Insomnia Medication Sales Value, by Application (2019-2030)
4.2.3 Global Insomnia Medication Sales Value, by Application (%) (2019-2030)
4.3 Global Insomnia Medication Sales Volume by Application
4.3.1 Global Insomnia Medication Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Insomnia Medication Sales Volume, by Application (2019-2030)
4.3.3 Global Insomnia Medication Sales Volume, by Application (%) (2019-2030)
4.4 Global Insomnia Medication Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Insomnia Medication Sales Value by Region
5.1.1 Global Insomnia Medication Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Insomnia Medication Sales Value by Region (2019-2024)
5.1.3 Global Insomnia Medication Sales Value by Region (2025-2030)
5.1.4 Global Insomnia Medication Sales Value by Region (%), (2019-2030)
5.2 Global Insomnia Medication Sales Volume by Region
5.2.1 Global Insomnia Medication Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Insomnia Medication Sales Volume by Region (2019-2024)
5.2.3 Global Insomnia Medication Sales Volume by Region (2025-2030)
5.2.4 Global Insomnia Medication Sales Volume by Region (%), (2019-2030)
5.3 Global Insomnia Medication Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Insomnia Medication Sales Value, 2019-2030
5.4.2 North America Insomnia Medication Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Insomnia Medication Sales Value, 2019-2030
5.5.2 Europe Insomnia Medication Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Insomnia Medication Sales Value, 2019-2030
5.6.2 Asia Pacific Insomnia Medication Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Insomnia Medication Sales Value, 2019-2030
5.7.2 South America Insomnia Medication Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Insomnia Medication Sales Value, 2019-2030
5.8.2 Middle East & Africa Insomnia Medication Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Insomnia Medication Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Insomnia Medication Sales Value
6.2.1 Key Countries/Regions Insomnia Medication Sales Value, 2019-2030
6.2.2 Key Countries/Regions Insomnia Medication Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Insomnia Medication Sales Value, 2019-2030
6.3.2 United States Insomnia Medication Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Insomnia Medication Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Insomnia Medication Sales Value, 2019-2030
6.4.2 Europe Insomnia Medication Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Insomnia Medication Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Insomnia Medication Sales Value, 2019-2030
6.5.2 China Insomnia Medication Sales Value by Type (%), 2023 VS 2030
6.5.3 China Insomnia Medication Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Insomnia Medication Sales Value, 2019-2030
6.6.2 Japan Insomnia Medication Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Insomnia Medication Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Insomnia Medication Sales Value, 2019-2030
6.7.2 South Korea Insomnia Medication Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Insomnia Medication Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Insomnia Medication Sales Value, 2019-2030
6.8.2 Southeast Asia Insomnia Medication Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Insomnia Medication Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Insomnia Medication Sales Value, 2019-2030
6.9.2 India Insomnia Medication Sales Value by Type (%), 2023 VS 2030
6.9.3 India Insomnia Medication Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Eisai
7.1.1 Eisai Company Information
7.1.2 Eisai Introduction and Business Overview
7.1.3 Eisai Insomnia Medication Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Eisai Insomnia Medication Product Offerings
7.1.5 Eisai Recent Development
7.2 Merck
7.2.1 Merck Company Information
7.2.2 Merck Introduction and Business Overview
7.2.3 Merck Insomnia Medication Sales, Revenue and Gross Margin (2019-2024)
7.2.4 Merck Insomnia Medication Product Offerings
7.2.5 Merck Recent Development
7.3 Pfizer
7.3.1 Pfizer Company Information
7.3.2 Pfizer Introduction and Business Overview
7.3.3 Pfizer Insomnia Medication Sales, Revenue and Gross Margin (2019-2024)
7.3.4 Pfizer Insomnia Medication Product Offerings
7.3.5 Pfizer Recent Development
7.4 Sanofi
7.4.1 Sanofi Company Information
7.4.2 Sanofi Introduction and Business Overview
7.4.3 Sanofi Insomnia Medication Sales, Revenue and Gross Margin (2019-2024)
7.4.4 Sanofi Insomnia Medication Product Offerings
7.4.5 Sanofi Recent Development
7.5 Takeda
7.5.1 Takeda Company Information
7.5.2 Takeda Introduction and Business Overview
7.5.3 Takeda Insomnia Medication Sales, Revenue and Gross Margin (2019-2024)
7.5.4 Takeda Insomnia Medication Product Offerings
7.5.5 Takeda Recent Development
7.6 Vanda Pharmaceuticals
7.6.1 Vanda Pharmaceuticals Company Information
7.6.2 Vanda Pharmaceuticals Introduction and Business Overview
7.6.3 Vanda Pharmaceuticals Insomnia Medication Sales, Revenue and Gross Margin (2019-2024)
7.6.4 Vanda Pharmaceuticals Insomnia Medication Product Offerings
7.6.5 Vanda Pharmaceuticals Recent Development
7.7 Astellas
7.7.1 Astellas Company Information
7.7.2 Astellas Introduction and Business Overview
7.7.3 Astellas Insomnia Medication Sales, Revenue and Gross Margin (2019-2024)
7.7.4 Astellas Insomnia Medication Product Offerings
7.7.5 Astellas Recent Development
7.8 Dainippon Sumitomo
7.8.1 Dainippon Sumitomo Company Information
7.8.2 Dainippon Sumitomo Introduction and Business Overview
7.8.3 Dainippon Sumitomo Insomnia Medication Sales, Revenue and Gross Margin (2019-2024)
7.8.4 Dainippon Sumitomo Insomnia Medication Product Offerings
7.8.5 Dainippon Sumitomo Recent Development
7.9 ECR Pharmaceuticals (Valeant)
7.9.1 ECR Pharmaceuticals (Valeant) Company Information
7.9.2 ECR Pharmaceuticals (Valeant) Introduction and Business Overview
7.9.3 ECR Pharmaceuticals (Valeant) Insomnia Medication Sales, Revenue and Gross Margin (2019-2024)
7.9.4 ECR Pharmaceuticals (Valeant) Insomnia Medication Product Offerings
7.9.5 ECR Pharmaceuticals (Valeant) Recent Development
7.10 Flynn Pharma
7.10.1 Flynn Pharma Company Information
7.10.2 Flynn Pharma Introduction and Business Overview
7.10.3 Flynn Pharma Insomnia Medication Sales, Revenue and Gross Margin (2019-2024)
7.10.4 Flynn Pharma Insomnia Medication Product Offerings
7.10.5 Flynn Pharma Recent Development
7.11 Johnson & Johnson
7.11.1 Johnson & Johnson Company Information
7.11.2 Johnson & Johnson Introduction and Business Overview
7.11.3 Johnson & Johnson Insomnia Medication Sales, Revenue and Gross Margin (2019-2024)
7.11.4 Johnson & Johnson Insomnia Medication Product Offerings
7.11.5 Johnson & Johnson Recent Development
7.12 Meda
7.12.1 Meda Company Information
7.12.2 Meda Introduction and Business Overview
7.12.3 Meda Insomnia Medication Sales, Revenue and Gross Margin (2019-2024)
7.12.4 Meda Insomnia Medication Product Offerings
7.12.5 Meda Recent Development
7.13 Somnus Therapeutics
7.13.1 Somnus Therapeutics Company Information
7.13.2 Somnus Therapeutics Introduction and Business Overview
7.13.3 Somnus Therapeutics Insomnia Medication Sales, Revenue and Gross Margin (2019-2024)
7.13.4 Somnus Therapeutics Insomnia Medication Product Offerings
7.13.5 Somnus Therapeutics Recent Development
7.14 Purdue Pharma
7.14.1 Purdue Pharma Company Information
7.14.2 Purdue Pharma Introduction and Business Overview
7.14.3 Purdue Pharma Insomnia Medication Sales, Revenue and Gross Margin (2019-2024)
7.14.4 Purdue Pharma Insomnia Medication Product Offerings
7.14.5 Purdue Pharma Recent Development
7.15 Neurim
7.15.1 Neurim Company Information
7.15.2 Neurim Introduction and Business Overview
7.15.3 Neurim Insomnia Medication Sales, Revenue and Gross Margin (2019-2024)
7.15.4 Neurim Insomnia Medication Product Offerings
7.15.5 Neurim Recent Development
7.16 Minerva Neurosciences
7.16.1 Minerva Neurosciences Company Information
7.16.2 Minerva Neurosciences Introduction and Business Overview
7.16.3 Minerva Neurosciences Insomnia Medication Sales, Revenue and Gross Margin (2019-2024)
7.16.4 Minerva Neurosciences Insomnia Medication Product Offerings
7.16.5 Minerva Neurosciences Recent Development
7.17 Pernix Therapeutics
7.17.1 Pernix Therapeutics Company Information
7.17.2 Pernix Therapeutics Introduction and Business Overview
7.17.3 Pernix Therapeutics Insomnia Medication Sales, Revenue and Gross Margin (2019-2024)
7.17.4 Pernix Therapeutics Insomnia Medication Product Offerings
7.17.5 Pernix Therapeutics Recent Development
7.18 SkyePharma
7.18.1 SkyePharma Company Information
7.18.2 SkyePharma Introduction and Business Overview
7.18.3 SkyePharma Insomnia Medication Sales, Revenue and Gross Margin (2019-2024)
7.18.4 SkyePharma Insomnia Medication Product Offerings
7.18.5 SkyePharma Recent Development
7.19 Paratek Pharmaceuticals
7.19.1 Paratek Pharmaceuticals Company Information
7.19.2 Paratek Pharmaceuticals Introduction and Business Overview
7.19.3 Paratek Pharmaceuticals Insomnia Medication Sales, Revenue and Gross Margin (2019-2024)
7.19.4 Paratek Pharmaceuticals Insomnia Medication Product Offerings
7.19.5 Paratek Pharmaceuticals Recent Development
8 Industry Chain Analysis
8.1 Insomnia Medication Industrial Chain
8.2 Insomnia Medication Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Insomnia Medication Sales Model
8.5.2 Sales Channel
8.5.3 Insomnia Medication Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
1.1 Insomnia Medication Product Introduction
1.2 Global Insomnia Medication Market Size Forecast
1.2.1 Global Insomnia Medication Sales Value (2019-2030)
1.2.2 Global Insomnia Medication Sales Volume (2019-2030)
1.2.3 Global Insomnia Medication Sales Price (2019-2030)
1.3 Insomnia Medication Market Trends & Drivers
1.3.1 Insomnia Medication Industry Trends
1.3.2 Insomnia Medication Market Drivers & Opportunity
1.3.3 Insomnia Medication Market Challenges
1.3.4 Insomnia Medication Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Insomnia Medication Players Revenue Ranking (2023)
2.2 Global Insomnia Medication Revenue by Company (2019-2024)
2.3 Global Insomnia Medication Players Sales Volume Ranking (2023)
2.4 Global Insomnia Medication Sales Volume by Company Players (2019-2024)
2.5 Global Insomnia Medication Average Price by Company (2019-2024)
2.6 Key Manufacturers Insomnia Medication Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Insomnia Medication Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Insomnia Medication
2.9 Insomnia Medication Market Competitive Analysis
2.9.1 Insomnia Medication Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Insomnia Medication Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Insomnia Medication as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Nonbenzodiazepine Receptor Agonists
3.1.2 Benzodiazepine Receptor Agonists
3.1.3 The Selective Melatonin Receptor Agonist Ramelteon
3.1.4 Sedating Antidepressants
3.2 Global Insomnia Medication Sales Value by Type
3.2.1 Global Insomnia Medication Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Insomnia Medication Sales Value, by Type (2019-2030)
3.2.3 Global Insomnia Medication Sales Value, by Type (%) (2019-2030)
3.3 Global Insomnia Medication Sales Volume by Type
3.3.1 Global Insomnia Medication Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Insomnia Medication Sales Volume, by Type (2019-2030)
3.3.3 Global Insomnia Medication Sales Volume, by Type (%) (2019-2030)
3.4 Global Insomnia Medication Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Adults
4.1.2 Kids
4.2 Global Insomnia Medication Sales Value by Application
4.2.1 Global Insomnia Medication Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Insomnia Medication Sales Value, by Application (2019-2030)
4.2.3 Global Insomnia Medication Sales Value, by Application (%) (2019-2030)
4.3 Global Insomnia Medication Sales Volume by Application
4.3.1 Global Insomnia Medication Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Insomnia Medication Sales Volume, by Application (2019-2030)
4.3.3 Global Insomnia Medication Sales Volume, by Application (%) (2019-2030)
4.4 Global Insomnia Medication Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Insomnia Medication Sales Value by Region
5.1.1 Global Insomnia Medication Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Insomnia Medication Sales Value by Region (2019-2024)
5.1.3 Global Insomnia Medication Sales Value by Region (2025-2030)
5.1.4 Global Insomnia Medication Sales Value by Region (%), (2019-2030)
5.2 Global Insomnia Medication Sales Volume by Region
5.2.1 Global Insomnia Medication Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Insomnia Medication Sales Volume by Region (2019-2024)
5.2.3 Global Insomnia Medication Sales Volume by Region (2025-2030)
5.2.4 Global Insomnia Medication Sales Volume by Region (%), (2019-2030)
5.3 Global Insomnia Medication Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Insomnia Medication Sales Value, 2019-2030
5.4.2 North America Insomnia Medication Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Insomnia Medication Sales Value, 2019-2030
5.5.2 Europe Insomnia Medication Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Insomnia Medication Sales Value, 2019-2030
5.6.2 Asia Pacific Insomnia Medication Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Insomnia Medication Sales Value, 2019-2030
5.7.2 South America Insomnia Medication Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Insomnia Medication Sales Value, 2019-2030
5.8.2 Middle East & Africa Insomnia Medication Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Insomnia Medication Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Insomnia Medication Sales Value
6.2.1 Key Countries/Regions Insomnia Medication Sales Value, 2019-2030
6.2.2 Key Countries/Regions Insomnia Medication Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Insomnia Medication Sales Value, 2019-2030
6.3.2 United States Insomnia Medication Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Insomnia Medication Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Insomnia Medication Sales Value, 2019-2030
6.4.2 Europe Insomnia Medication Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Insomnia Medication Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Insomnia Medication Sales Value, 2019-2030
6.5.2 China Insomnia Medication Sales Value by Type (%), 2023 VS 2030
6.5.3 China Insomnia Medication Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Insomnia Medication Sales Value, 2019-2030
6.6.2 Japan Insomnia Medication Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Insomnia Medication Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Insomnia Medication Sales Value, 2019-2030
6.7.2 South Korea Insomnia Medication Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Insomnia Medication Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Insomnia Medication Sales Value, 2019-2030
6.8.2 Southeast Asia Insomnia Medication Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Insomnia Medication Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Insomnia Medication Sales Value, 2019-2030
6.9.2 India Insomnia Medication Sales Value by Type (%), 2023 VS 2030
6.9.3 India Insomnia Medication Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Eisai
7.1.1 Eisai Company Information
7.1.2 Eisai Introduction and Business Overview
7.1.3 Eisai Insomnia Medication Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Eisai Insomnia Medication Product Offerings
7.1.5 Eisai Recent Development
7.2 Merck
7.2.1 Merck Company Information
7.2.2 Merck Introduction and Business Overview
7.2.3 Merck Insomnia Medication Sales, Revenue and Gross Margin (2019-2024)
7.2.4 Merck Insomnia Medication Product Offerings
7.2.5 Merck Recent Development
7.3 Pfizer
7.3.1 Pfizer Company Information
7.3.2 Pfizer Introduction and Business Overview
7.3.3 Pfizer Insomnia Medication Sales, Revenue and Gross Margin (2019-2024)
7.3.4 Pfizer Insomnia Medication Product Offerings
7.3.5 Pfizer Recent Development
7.4 Sanofi
7.4.1 Sanofi Company Information
7.4.2 Sanofi Introduction and Business Overview
7.4.3 Sanofi Insomnia Medication Sales, Revenue and Gross Margin (2019-2024)
7.4.4 Sanofi Insomnia Medication Product Offerings
7.4.5 Sanofi Recent Development
7.5 Takeda
7.5.1 Takeda Company Information
7.5.2 Takeda Introduction and Business Overview
7.5.3 Takeda Insomnia Medication Sales, Revenue and Gross Margin (2019-2024)
7.5.4 Takeda Insomnia Medication Product Offerings
7.5.5 Takeda Recent Development
7.6 Vanda Pharmaceuticals
7.6.1 Vanda Pharmaceuticals Company Information
7.6.2 Vanda Pharmaceuticals Introduction and Business Overview
7.6.3 Vanda Pharmaceuticals Insomnia Medication Sales, Revenue and Gross Margin (2019-2024)
7.6.4 Vanda Pharmaceuticals Insomnia Medication Product Offerings
7.6.5 Vanda Pharmaceuticals Recent Development
7.7 Astellas
7.7.1 Astellas Company Information
7.7.2 Astellas Introduction and Business Overview
7.7.3 Astellas Insomnia Medication Sales, Revenue and Gross Margin (2019-2024)
7.7.4 Astellas Insomnia Medication Product Offerings
7.7.5 Astellas Recent Development
7.8 Dainippon Sumitomo
7.8.1 Dainippon Sumitomo Company Information
7.8.2 Dainippon Sumitomo Introduction and Business Overview
7.8.3 Dainippon Sumitomo Insomnia Medication Sales, Revenue and Gross Margin (2019-2024)
7.8.4 Dainippon Sumitomo Insomnia Medication Product Offerings
7.8.5 Dainippon Sumitomo Recent Development
7.9 ECR Pharmaceuticals (Valeant)
7.9.1 ECR Pharmaceuticals (Valeant) Company Information
7.9.2 ECR Pharmaceuticals (Valeant) Introduction and Business Overview
7.9.3 ECR Pharmaceuticals (Valeant) Insomnia Medication Sales, Revenue and Gross Margin (2019-2024)
7.9.4 ECR Pharmaceuticals (Valeant) Insomnia Medication Product Offerings
7.9.5 ECR Pharmaceuticals (Valeant) Recent Development
7.10 Flynn Pharma
7.10.1 Flynn Pharma Company Information
7.10.2 Flynn Pharma Introduction and Business Overview
7.10.3 Flynn Pharma Insomnia Medication Sales, Revenue and Gross Margin (2019-2024)
7.10.4 Flynn Pharma Insomnia Medication Product Offerings
7.10.5 Flynn Pharma Recent Development
7.11 Johnson & Johnson
7.11.1 Johnson & Johnson Company Information
7.11.2 Johnson & Johnson Introduction and Business Overview
7.11.3 Johnson & Johnson Insomnia Medication Sales, Revenue and Gross Margin (2019-2024)
7.11.4 Johnson & Johnson Insomnia Medication Product Offerings
7.11.5 Johnson & Johnson Recent Development
7.12 Meda
7.12.1 Meda Company Information
7.12.2 Meda Introduction and Business Overview
7.12.3 Meda Insomnia Medication Sales, Revenue and Gross Margin (2019-2024)
7.12.4 Meda Insomnia Medication Product Offerings
7.12.5 Meda Recent Development
7.13 Somnus Therapeutics
7.13.1 Somnus Therapeutics Company Information
7.13.2 Somnus Therapeutics Introduction and Business Overview
7.13.3 Somnus Therapeutics Insomnia Medication Sales, Revenue and Gross Margin (2019-2024)
7.13.4 Somnus Therapeutics Insomnia Medication Product Offerings
7.13.5 Somnus Therapeutics Recent Development
7.14 Purdue Pharma
7.14.1 Purdue Pharma Company Information
7.14.2 Purdue Pharma Introduction and Business Overview
7.14.3 Purdue Pharma Insomnia Medication Sales, Revenue and Gross Margin (2019-2024)
7.14.4 Purdue Pharma Insomnia Medication Product Offerings
7.14.5 Purdue Pharma Recent Development
7.15 Neurim
7.15.1 Neurim Company Information
7.15.2 Neurim Introduction and Business Overview
7.15.3 Neurim Insomnia Medication Sales, Revenue and Gross Margin (2019-2024)
7.15.4 Neurim Insomnia Medication Product Offerings
7.15.5 Neurim Recent Development
7.16 Minerva Neurosciences
7.16.1 Minerva Neurosciences Company Information
7.16.2 Minerva Neurosciences Introduction and Business Overview
7.16.3 Minerva Neurosciences Insomnia Medication Sales, Revenue and Gross Margin (2019-2024)
7.16.4 Minerva Neurosciences Insomnia Medication Product Offerings
7.16.5 Minerva Neurosciences Recent Development
7.17 Pernix Therapeutics
7.17.1 Pernix Therapeutics Company Information
7.17.2 Pernix Therapeutics Introduction and Business Overview
7.17.3 Pernix Therapeutics Insomnia Medication Sales, Revenue and Gross Margin (2019-2024)
7.17.4 Pernix Therapeutics Insomnia Medication Product Offerings
7.17.5 Pernix Therapeutics Recent Development
7.18 SkyePharma
7.18.1 SkyePharma Company Information
7.18.2 SkyePharma Introduction and Business Overview
7.18.3 SkyePharma Insomnia Medication Sales, Revenue and Gross Margin (2019-2024)
7.18.4 SkyePharma Insomnia Medication Product Offerings
7.18.5 SkyePharma Recent Development
7.19 Paratek Pharmaceuticals
7.19.1 Paratek Pharmaceuticals Company Information
7.19.2 Paratek Pharmaceuticals Introduction and Business Overview
7.19.3 Paratek Pharmaceuticals Insomnia Medication Sales, Revenue and Gross Margin (2019-2024)
7.19.4 Paratek Pharmaceuticals Insomnia Medication Product Offerings
7.19.5 Paratek Pharmaceuticals Recent Development
8 Industry Chain Analysis
8.1 Insomnia Medication Industrial Chain
8.2 Insomnia Medication Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Insomnia Medication Sales Model
8.5.2 Sales Channel
8.5.3 Insomnia Medication Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
Table 1. Insomnia Medication Market Trends
Table 2. Insomnia Medication Market Drivers & Opportunity
Table 3. Insomnia Medication Market Challenges
Table 4. Insomnia Medication Market Restraints
Table 5. Global Insomnia Medication Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Insomnia Medication Revenue Market Share by Company (2019-2024)
Table 7. Global Insomnia Medication Sales Volume by Company (2019-2024) & (K Pcs)
Table 8. Global Insomnia Medication Sales Volume Market Share by Company (2019-2024)
Table 9. Global Market Insomnia Medication Price by Company (2019-2024) & (USD/Pcs)
Table 10. Key Manufacturers Insomnia Medication Manufacturing Base Distribution and Headquarters
Table 11. Key Manufacturers Insomnia Medication Product Type
Table 12. Key Manufacturers Time to Begin Mass Production of Insomnia Medication
Table 13. Global Insomnia Medication Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Insomnia Medication as of 2023)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Global Insomnia Medication Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 17. Global Insomnia Medication Sales Value by Type (2019-2024) & (US$ Million)
Table 18. Global Insomnia Medication Sales Value by Type (2025-2030) & (US$ Million)
Table 19. Global Insomnia Medication Sales Market Share in Value by Type (2019-2024) & (%)
Table 20. Global Insomnia Medication Sales Market Share in Value by Type (2025-2030) & (%)
Table 21. Global Insomnia Medication Sales Volume by Type: 2019 VS 2023 VS 2030 (K Pcs)
Table 22. Global Insomnia Medication Sales Volume by Type (2019-2024) & (K Pcs)
Table 23. Global Insomnia Medication Sales Volume by Type (2025-2030) & (K Pcs)
Table 24. Global Insomnia Medication Sales Market Share in Volume by Type (2019-2024) & (%)
Table 25. Global Insomnia Medication Sales Market Share in Volume by Type (2025-2030) & (%)
Table 26. Global Insomnia Medication Price by Type (2019-2024) & (USD/Pcs)
Table 27. Global Insomnia Medication Price by Type (2025-2030) & (USD/Pcs)
Table 28. Global Insomnia Medication Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 29. Global Insomnia Medication Sales Value by Application (2019-2024) & (US$ Million)
Table 30. Global Insomnia Medication Sales Value by Application (2025-2030) & (US$ Million)
Table 31. Global Insomnia Medication Sales Market Share in Value by Application (2019-2024) & (%)
Table 32. Global Insomnia Medication Sales Market Share in Value by Application (2025-2030) & (%)
Table 33. Global Insomnia Medication Sales Volume by Application: 2019 VS 2023 VS 2030 (K Pcs)
Table 34. Global Insomnia Medication Sales Volume by Application (2019-2024) & (K Pcs)
Table 35. Global Insomnia Medication Sales Volume by Application (2025-2030) & (K Pcs)
Table 36. Global Insomnia Medication Sales Market Share in Volume by Application (2019-2024) & (%)
Table 37. Global Insomnia Medication Sales Market Share in Volume by Application (2025-2030) & (%)
Table 38. Global Insomnia Medication Price by Application (2019-2024) & (USD/Pcs)
Table 39. Global Insomnia Medication Price by Application (2025-2030) & (USD/Pcs)
Table 40. Global Insomnia Medication Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Global Insomnia Medication Sales Value by Region (2019-2024) & (US$ Million)
Table 42. Global Insomnia Medication Sales Value by Region (2025-2030) & (US$ Million)
Table 43. Global Insomnia Medication Sales Value by Region (2019-2024) & (%)
Table 44. Global Insomnia Medication Sales Value by Region (2025-2030) & (%)
Table 45. Global Insomnia Medication Sales Volume by Region (K Pcs): 2019 VS 2023 VS 2030
Table 46. Global Insomnia Medication Sales Volume by Region (2019-2024) & (K Pcs)
Table 47. Global Insomnia Medication Sales Volume by Region (2025-2030) & (K Pcs)
Table 48. Global Insomnia Medication Sales Volume by Region (2019-2024) & (%)
Table 49. Global Insomnia Medication Sales Volume by Region (2025-2030) & (%)
Table 50. Global Insomnia Medication Average Price by Region (2019-2024) & (USD/Pcs)
Table 51. Global Insomnia Medication Average Price by Region (2025-2030) & (USD/Pcs)
Table 52. Key Countries/Regions Insomnia Medication Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 53. Key Countries/Regions Insomnia Medication Sales Value, (2019-2024) & (US$ Million)
Table 54. Key Countries/Regions Insomnia Medication Sales Value, (2025-2030) & (US$ Million)
Table 55. Key Countries/Regions Insomnia Medication Sales Volume, (2019-2024) & (K Pcs)
Table 56. Key Countries/Regions Insomnia Medication Sales Volume, (2025-2030) & (K Pcs)
Table 57. Eisai Company Information
Table 58. Eisai Introduction and Business Overview
Table 59. Eisai Insomnia Medication Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 60. Eisai Insomnia Medication Product Offerings
Table 61. Eisai Recent Development
Table 62. Merck Company Information
Table 63. Merck Introduction and Business Overview
Table 64. Merck Insomnia Medication Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 65. Merck Insomnia Medication Product Offerings
Table 66. Merck Recent Development
Table 67. Pfizer Company Information
Table 68. Pfizer Introduction and Business Overview
Table 69. Pfizer Insomnia Medication Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 70. Pfizer Insomnia Medication Product Offerings
Table 71. Pfizer Recent Development
Table 72. Sanofi Company Information
Table 73. Sanofi Introduction and Business Overview
Table 74. Sanofi Insomnia Medication Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 75. Sanofi Insomnia Medication Product Offerings
Table 76. Sanofi Recent Development
Table 77. Takeda Company Information
Table 78. Takeda Introduction and Business Overview
Table 79. Takeda Insomnia Medication Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 80. Takeda Insomnia Medication Product Offerings
Table 81. Takeda Recent Development
Table 82. Vanda Pharmaceuticals Company Information
Table 83. Vanda Pharmaceuticals Introduction and Business Overview
Table 84. Vanda Pharmaceuticals Insomnia Medication Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 85. Vanda Pharmaceuticals Insomnia Medication Product Offerings
Table 86. Vanda Pharmaceuticals Recent Development
Table 87. Astellas Company Information
Table 88. Astellas Introduction and Business Overview
Table 89. Astellas Insomnia Medication Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 90. Astellas Insomnia Medication Product Offerings
Table 91. Astellas Recent Development
Table 92. Dainippon Sumitomo Company Information
Table 93. Dainippon Sumitomo Introduction and Business Overview
Table 94. Dainippon Sumitomo Insomnia Medication Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 95. Dainippon Sumitomo Insomnia Medication Product Offerings
Table 96. Dainippon Sumitomo Recent Development
Table 97. ECR Pharmaceuticals (Valeant) Company Information
Table 98. ECR Pharmaceuticals (Valeant) Introduction and Business Overview
Table 99. ECR Pharmaceuticals (Valeant) Insomnia Medication Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 100. ECR Pharmaceuticals (Valeant) Insomnia Medication Product Offerings
Table 101. ECR Pharmaceuticals (Valeant) Recent Development
Table 102. Flynn Pharma Company Information
Table 103. Flynn Pharma Introduction and Business Overview
Table 104. Flynn Pharma Insomnia Medication Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 105. Flynn Pharma Insomnia Medication Product Offerings
Table 106. Flynn Pharma Recent Development
Table 107. Johnson & Johnson Company Information
Table 108. Johnson & Johnson Introduction and Business Overview
Table 109. Johnson & Johnson Insomnia Medication Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 110. Johnson & Johnson Insomnia Medication Product Offerings
Table 111. Johnson & Johnson Recent Development
Table 112. Meda Company Information
Table 113. Meda Introduction and Business Overview
Table 114. Meda Insomnia Medication Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 115. Meda Insomnia Medication Product Offerings
Table 116. Meda Recent Development
Table 117. Somnus Therapeutics Company Information
Table 118. Somnus Therapeutics Introduction and Business Overview
Table 119. Somnus Therapeutics Insomnia Medication Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 120. Somnus Therapeutics Insomnia Medication Product Offerings
Table 121. Somnus Therapeutics Recent Development
Table 122. Purdue Pharma Company Information
Table 123. Purdue Pharma Introduction and Business Overview
Table 124. Purdue Pharma Insomnia Medication Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 125. Purdue Pharma Insomnia Medication Product Offerings
Table 126. Purdue Pharma Recent Development
Table 127. Neurim Company Information
Table 128. Neurim Introduction and Business Overview
Table 129. Neurim Insomnia Medication Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 130. Neurim Insomnia Medication Product Offerings
Table 131. Neurim Recent Development
Table 132. Minerva Neurosciences Company Information
Table 133. Minerva Neurosciences Introduction and Business Overview
Table 134. Minerva Neurosciences Insomnia Medication Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 135. Minerva Neurosciences Insomnia Medication Product Offerings
Table 136. Minerva Neurosciences Recent Development
Table 137. Pernix Therapeutics Company Information
Table 138. Pernix Therapeutics Introduction and Business Overview
Table 139. Pernix Therapeutics Insomnia Medication Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 140. Pernix Therapeutics Insomnia Medication Product Offerings
Table 141. Pernix Therapeutics Recent Development
Table 142. SkyePharma Company Information
Table 143. SkyePharma Introduction and Business Overview
Table 144. SkyePharma Insomnia Medication Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 145. SkyePharma Insomnia Medication Product Offerings
Table 146. SkyePharma Recent Development
Table 147. Paratek Pharmaceuticals Company Information
Table 148. Paratek Pharmaceuticals Introduction and Business Overview
Table 149. Paratek Pharmaceuticals Insomnia Medication Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 150. Paratek Pharmaceuticals Insomnia Medication Product Offerings
Table 151. Paratek Pharmaceuticals Recent Development
Table 152. Key Raw Materials Lists
Table 153. Raw Materials Key Suppliers Lists
Table 154. Insomnia Medication Downstream Customers
Table 155. Insomnia Medication Distributors List
Table 156. Research Programs/Design for This Report
Table 157. Key Data Information from Secondary Sources
Table 158. Key Data Information from Primary Sources
List of Figures
Figure 1. Insomnia Medication Product Picture
Figure 2. Global Insomnia Medication Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Insomnia Medication Sales Value (2019-2030) & (US$ Million)
Figure 4. Global Insomnia Medication Sales Volume (2019-2030) & (K Pcs)
Figure 5. Global Insomnia Medication Sales Price (2019-2030) & (USD/Pcs)
Figure 6. Insomnia Medication Report Years Considered
Figure 7. Global Insomnia Medication Players Revenue Ranking (2023) & (US$ Million)
Figure 8. Global Insomnia Medication Players Sales Volume Ranking (2023) & (K Pcs)
Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Insomnia Medication Revenue in 2023
Figure 10. Insomnia Medication Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 11. Nonbenzodiazepine Receptor Agonists Picture
Figure 12. Benzodiazepine Receptor Agonists Picture
Figure 13. The Selective Melatonin Receptor Agonist Ramelteon Picture
Figure 14. Sedating Antidepressants Picture
Figure 15. Global Insomnia Medication Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 16. Global Insomnia Medication Sales Value Market Share by Type, 2023 & 2030
Figure 17. Global Insomnia Medication Sales Volume by Type (2019 VS 2023 VS 2030) & (K Pcs)
Figure 18. Global Insomnia Medication Sales Volume Market Share by Type, 2023 & 2030
Figure 19. Global Insomnia Medication Price by Type (2019-2030) & (USD/Pcs)
Figure 20. Product Picture of Adults
Figure 21. Product Picture of Kids
Figure 22. Global Insomnia Medication Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 23. Global Insomnia Medication Sales Value Market Share by Application, 2023 & 2030
Figure 24. Global Insomnia Medication Sales Volume by Application (2019 VS 2023 VS 2030) & (K Pcs)
Figure 25. Global Insomnia Medication Sales Volume Market Share by Application, 2023 & 2030
Figure 26. Global Insomnia Medication Price by Application (2019-2030) & (USD/Pcs)
Figure 27. North America Insomnia Medication Sales Value (2019-2030) & (US$ Million)
Figure 28. North America Insomnia Medication Sales Value by Country (%), 2023 VS 2030
Figure 29. Europe Insomnia Medication Sales Value (2019-2030) & (US$ Million)
Figure 30. Europe Insomnia Medication Sales Value by Country (%), 2023 VS 2030
Figure 31. Asia Pacific Insomnia Medication Sales Value (2019-2030) & (US$ Million)
Figure 32. Asia Pacific Insomnia Medication Sales Value by Country (%), 2023 VS 2030
Figure 33. South America Insomnia Medication Sales Value (2019-2030) & (US$ Million)
Figure 34. South America Insomnia Medication Sales Value by Country (%), 2023 VS 2030
Figure 35. Middle East & Africa Insomnia Medication Sales Value (2019-2030) & (US$ Million)
Figure 36. Middle East & Africa Insomnia Medication Sales Value by Country (%), 2023 VS 2030
Figure 37. Key Countries/Regions Insomnia Medication Sales Value (%), (2019-2030)
Figure 38. Key Countries/Regions Insomnia Medication Sales Volume (%), (2019-2030)
Figure 39. United States Insomnia Medication Sales Value, (2019-2030) & (US$ Million)
Figure 40. United States Insomnia Medication Sales Value by Type (%), 2023 VS 2030
Figure 41. United States Insomnia Medication Sales Value by Application (%), 2023 VS 2030
Figure 42. Europe Insomnia Medication Sales Value, (2019-2030) & (US$ Million)
Figure 43. Europe Insomnia Medication Sales Value by Type (%), 2023 VS 2030
Figure 44. Europe Insomnia Medication Sales Value by Application (%), 2023 VS 2030
Figure 45. China Insomnia Medication Sales Value, (2019-2030) & (US$ Million)
Figure 46. China Insomnia Medication Sales Value by Type (%), 2023 VS 2030
Figure 47. China Insomnia Medication Sales Value by Application (%), 2023 VS 2030
Figure 48. Japan Insomnia Medication Sales Value, (2019-2030) & (US$ Million)
Figure 49. Japan Insomnia Medication Sales Value by Type (%), 2023 VS 2030
Figure 50. Japan Insomnia Medication Sales Value by Application (%), 2023 VS 2030
Figure 51. South Korea Insomnia Medication Sales Value, (2019-2030) & (US$ Million)
Figure 52. South Korea Insomnia Medication Sales Value by Type (%), 2023 VS 2030
Figure 53. South Korea Insomnia Medication Sales Value by Application (%), 2023 VS 2030
Figure 54. Southeast Asia Insomnia Medication Sales Value, (2019-2030) & (US$ Million)
Figure 55. Southeast Asia Insomnia Medication Sales Value by Type (%), 2023 VS 2030
Figure 56. Southeast Asia Insomnia Medication Sales Value by Application (%), 2023 VS 2030
Figure 57. India Insomnia Medication Sales Value, (2019-2030) & (US$ Million)
Figure 58. India Insomnia Medication Sales Value by Type (%), 2023 VS 2030
Figure 59. India Insomnia Medication Sales Value by Application (%), 2023 VS 2030
Figure 60. Insomnia Medication Industrial Chain
Figure 61. Insomnia Medication Manufacturing Cost Structure
Figure 62. Channels of Distribution (Direct Sales, and Distribution)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
Table 1. Insomnia Medication Market Trends
Table 2. Insomnia Medication Market Drivers & Opportunity
Table 3. Insomnia Medication Market Challenges
Table 4. Insomnia Medication Market Restraints
Table 5. Global Insomnia Medication Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Insomnia Medication Revenue Market Share by Company (2019-2024)
Table 7. Global Insomnia Medication Sales Volume by Company (2019-2024) & (K Pcs)
Table 8. Global Insomnia Medication Sales Volume Market Share by Company (2019-2024)
Table 9. Global Market Insomnia Medication Price by Company (2019-2024) & (USD/Pcs)
Table 10. Key Manufacturers Insomnia Medication Manufacturing Base Distribution and Headquarters
Table 11. Key Manufacturers Insomnia Medication Product Type
Table 12. Key Manufacturers Time to Begin Mass Production of Insomnia Medication
Table 13. Global Insomnia Medication Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Insomnia Medication as of 2023)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Global Insomnia Medication Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 17. Global Insomnia Medication Sales Value by Type (2019-2024) & (US$ Million)
Table 18. Global Insomnia Medication Sales Value by Type (2025-2030) & (US$ Million)
Table 19. Global Insomnia Medication Sales Market Share in Value by Type (2019-2024) & (%)
Table 20. Global Insomnia Medication Sales Market Share in Value by Type (2025-2030) & (%)
Table 21. Global Insomnia Medication Sales Volume by Type: 2019 VS 2023 VS 2030 (K Pcs)
Table 22. Global Insomnia Medication Sales Volume by Type (2019-2024) & (K Pcs)
Table 23. Global Insomnia Medication Sales Volume by Type (2025-2030) & (K Pcs)
Table 24. Global Insomnia Medication Sales Market Share in Volume by Type (2019-2024) & (%)
Table 25. Global Insomnia Medication Sales Market Share in Volume by Type (2025-2030) & (%)
Table 26. Global Insomnia Medication Price by Type (2019-2024) & (USD/Pcs)
Table 27. Global Insomnia Medication Price by Type (2025-2030) & (USD/Pcs)
Table 28. Global Insomnia Medication Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 29. Global Insomnia Medication Sales Value by Application (2019-2024) & (US$ Million)
Table 30. Global Insomnia Medication Sales Value by Application (2025-2030) & (US$ Million)
Table 31. Global Insomnia Medication Sales Market Share in Value by Application (2019-2024) & (%)
Table 32. Global Insomnia Medication Sales Market Share in Value by Application (2025-2030) & (%)
Table 33. Global Insomnia Medication Sales Volume by Application: 2019 VS 2023 VS 2030 (K Pcs)
Table 34. Global Insomnia Medication Sales Volume by Application (2019-2024) & (K Pcs)
Table 35. Global Insomnia Medication Sales Volume by Application (2025-2030) & (K Pcs)
Table 36. Global Insomnia Medication Sales Market Share in Volume by Application (2019-2024) & (%)
Table 37. Global Insomnia Medication Sales Market Share in Volume by Application (2025-2030) & (%)
Table 38. Global Insomnia Medication Price by Application (2019-2024) & (USD/Pcs)
Table 39. Global Insomnia Medication Price by Application (2025-2030) & (USD/Pcs)
Table 40. Global Insomnia Medication Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Global Insomnia Medication Sales Value by Region (2019-2024) & (US$ Million)
Table 42. Global Insomnia Medication Sales Value by Region (2025-2030) & (US$ Million)
Table 43. Global Insomnia Medication Sales Value by Region (2019-2024) & (%)
Table 44. Global Insomnia Medication Sales Value by Region (2025-2030) & (%)
Table 45. Global Insomnia Medication Sales Volume by Region (K Pcs): 2019 VS 2023 VS 2030
Table 46. Global Insomnia Medication Sales Volume by Region (2019-2024) & (K Pcs)
Table 47. Global Insomnia Medication Sales Volume by Region (2025-2030) & (K Pcs)
Table 48. Global Insomnia Medication Sales Volume by Region (2019-2024) & (%)
Table 49. Global Insomnia Medication Sales Volume by Region (2025-2030) & (%)
Table 50. Global Insomnia Medication Average Price by Region (2019-2024) & (USD/Pcs)
Table 51. Global Insomnia Medication Average Price by Region (2025-2030) & (USD/Pcs)
Table 52. Key Countries/Regions Insomnia Medication Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 53. Key Countries/Regions Insomnia Medication Sales Value, (2019-2024) & (US$ Million)
Table 54. Key Countries/Regions Insomnia Medication Sales Value, (2025-2030) & (US$ Million)
Table 55. Key Countries/Regions Insomnia Medication Sales Volume, (2019-2024) & (K Pcs)
Table 56. Key Countries/Regions Insomnia Medication Sales Volume, (2025-2030) & (K Pcs)
Table 57. Eisai Company Information
Table 58. Eisai Introduction and Business Overview
Table 59. Eisai Insomnia Medication Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 60. Eisai Insomnia Medication Product Offerings
Table 61. Eisai Recent Development
Table 62. Merck Company Information
Table 63. Merck Introduction and Business Overview
Table 64. Merck Insomnia Medication Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 65. Merck Insomnia Medication Product Offerings
Table 66. Merck Recent Development
Table 67. Pfizer Company Information
Table 68. Pfizer Introduction and Business Overview
Table 69. Pfizer Insomnia Medication Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 70. Pfizer Insomnia Medication Product Offerings
Table 71. Pfizer Recent Development
Table 72. Sanofi Company Information
Table 73. Sanofi Introduction and Business Overview
Table 74. Sanofi Insomnia Medication Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 75. Sanofi Insomnia Medication Product Offerings
Table 76. Sanofi Recent Development
Table 77. Takeda Company Information
Table 78. Takeda Introduction and Business Overview
Table 79. Takeda Insomnia Medication Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 80. Takeda Insomnia Medication Product Offerings
Table 81. Takeda Recent Development
Table 82. Vanda Pharmaceuticals Company Information
Table 83. Vanda Pharmaceuticals Introduction and Business Overview
Table 84. Vanda Pharmaceuticals Insomnia Medication Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 85. Vanda Pharmaceuticals Insomnia Medication Product Offerings
Table 86. Vanda Pharmaceuticals Recent Development
Table 87. Astellas Company Information
Table 88. Astellas Introduction and Business Overview
Table 89. Astellas Insomnia Medication Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 90. Astellas Insomnia Medication Product Offerings
Table 91. Astellas Recent Development
Table 92. Dainippon Sumitomo Company Information
Table 93. Dainippon Sumitomo Introduction and Business Overview
Table 94. Dainippon Sumitomo Insomnia Medication Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 95. Dainippon Sumitomo Insomnia Medication Product Offerings
Table 96. Dainippon Sumitomo Recent Development
Table 97. ECR Pharmaceuticals (Valeant) Company Information
Table 98. ECR Pharmaceuticals (Valeant) Introduction and Business Overview
Table 99. ECR Pharmaceuticals (Valeant) Insomnia Medication Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 100. ECR Pharmaceuticals (Valeant) Insomnia Medication Product Offerings
Table 101. ECR Pharmaceuticals (Valeant) Recent Development
Table 102. Flynn Pharma Company Information
Table 103. Flynn Pharma Introduction and Business Overview
Table 104. Flynn Pharma Insomnia Medication Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 105. Flynn Pharma Insomnia Medication Product Offerings
Table 106. Flynn Pharma Recent Development
Table 107. Johnson & Johnson Company Information
Table 108. Johnson & Johnson Introduction and Business Overview
Table 109. Johnson & Johnson Insomnia Medication Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 110. Johnson & Johnson Insomnia Medication Product Offerings
Table 111. Johnson & Johnson Recent Development
Table 112. Meda Company Information
Table 113. Meda Introduction and Business Overview
Table 114. Meda Insomnia Medication Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 115. Meda Insomnia Medication Product Offerings
Table 116. Meda Recent Development
Table 117. Somnus Therapeutics Company Information
Table 118. Somnus Therapeutics Introduction and Business Overview
Table 119. Somnus Therapeutics Insomnia Medication Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 120. Somnus Therapeutics Insomnia Medication Product Offerings
Table 121. Somnus Therapeutics Recent Development
Table 122. Purdue Pharma Company Information
Table 123. Purdue Pharma Introduction and Business Overview
Table 124. Purdue Pharma Insomnia Medication Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 125. Purdue Pharma Insomnia Medication Product Offerings
Table 126. Purdue Pharma Recent Development
Table 127. Neurim Company Information
Table 128. Neurim Introduction and Business Overview
Table 129. Neurim Insomnia Medication Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 130. Neurim Insomnia Medication Product Offerings
Table 131. Neurim Recent Development
Table 132. Minerva Neurosciences Company Information
Table 133. Minerva Neurosciences Introduction and Business Overview
Table 134. Minerva Neurosciences Insomnia Medication Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 135. Minerva Neurosciences Insomnia Medication Product Offerings
Table 136. Minerva Neurosciences Recent Development
Table 137. Pernix Therapeutics Company Information
Table 138. Pernix Therapeutics Introduction and Business Overview
Table 139. Pernix Therapeutics Insomnia Medication Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 140. Pernix Therapeutics Insomnia Medication Product Offerings
Table 141. Pernix Therapeutics Recent Development
Table 142. SkyePharma Company Information
Table 143. SkyePharma Introduction and Business Overview
Table 144. SkyePharma Insomnia Medication Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 145. SkyePharma Insomnia Medication Product Offerings
Table 146. SkyePharma Recent Development
Table 147. Paratek Pharmaceuticals Company Information
Table 148. Paratek Pharmaceuticals Introduction and Business Overview
Table 149. Paratek Pharmaceuticals Insomnia Medication Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 150. Paratek Pharmaceuticals Insomnia Medication Product Offerings
Table 151. Paratek Pharmaceuticals Recent Development
Table 152. Key Raw Materials Lists
Table 153. Raw Materials Key Suppliers Lists
Table 154. Insomnia Medication Downstream Customers
Table 155. Insomnia Medication Distributors List
Table 156. Research Programs/Design for This Report
Table 157. Key Data Information from Secondary Sources
Table 158. Key Data Information from Primary Sources
List of Figures
Figure 1. Insomnia Medication Product Picture
Figure 2. Global Insomnia Medication Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Insomnia Medication Sales Value (2019-2030) & (US$ Million)
Figure 4. Global Insomnia Medication Sales Volume (2019-2030) & (K Pcs)
Figure 5. Global Insomnia Medication Sales Price (2019-2030) & (USD/Pcs)
Figure 6. Insomnia Medication Report Years Considered
Figure 7. Global Insomnia Medication Players Revenue Ranking (2023) & (US$ Million)
Figure 8. Global Insomnia Medication Players Sales Volume Ranking (2023) & (K Pcs)
Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Insomnia Medication Revenue in 2023
Figure 10. Insomnia Medication Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 11. Nonbenzodiazepine Receptor Agonists Picture
Figure 12. Benzodiazepine Receptor Agonists Picture
Figure 13. The Selective Melatonin Receptor Agonist Ramelteon Picture
Figure 14. Sedating Antidepressants Picture
Figure 15. Global Insomnia Medication Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 16. Global Insomnia Medication Sales Value Market Share by Type, 2023 & 2030
Figure 17. Global Insomnia Medication Sales Volume by Type (2019 VS 2023 VS 2030) & (K Pcs)
Figure 18. Global Insomnia Medication Sales Volume Market Share by Type, 2023 & 2030
Figure 19. Global Insomnia Medication Price by Type (2019-2030) & (USD/Pcs)
Figure 20. Product Picture of Adults
Figure 21. Product Picture of Kids
Figure 22. Global Insomnia Medication Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 23. Global Insomnia Medication Sales Value Market Share by Application, 2023 & 2030
Figure 24. Global Insomnia Medication Sales Volume by Application (2019 VS 2023 VS 2030) & (K Pcs)
Figure 25. Global Insomnia Medication Sales Volume Market Share by Application, 2023 & 2030
Figure 26. Global Insomnia Medication Price by Application (2019-2030) & (USD/Pcs)
Figure 27. North America Insomnia Medication Sales Value (2019-2030) & (US$ Million)
Figure 28. North America Insomnia Medication Sales Value by Country (%), 2023 VS 2030
Figure 29. Europe Insomnia Medication Sales Value (2019-2030) & (US$ Million)
Figure 30. Europe Insomnia Medication Sales Value by Country (%), 2023 VS 2030
Figure 31. Asia Pacific Insomnia Medication Sales Value (2019-2030) & (US$ Million)
Figure 32. Asia Pacific Insomnia Medication Sales Value by Country (%), 2023 VS 2030
Figure 33. South America Insomnia Medication Sales Value (2019-2030) & (US$ Million)
Figure 34. South America Insomnia Medication Sales Value by Country (%), 2023 VS 2030
Figure 35. Middle East & Africa Insomnia Medication Sales Value (2019-2030) & (US$ Million)
Figure 36. Middle East & Africa Insomnia Medication Sales Value by Country (%), 2023 VS 2030
Figure 37. Key Countries/Regions Insomnia Medication Sales Value (%), (2019-2030)
Figure 38. Key Countries/Regions Insomnia Medication Sales Volume (%), (2019-2030)
Figure 39. United States Insomnia Medication Sales Value, (2019-2030) & (US$ Million)
Figure 40. United States Insomnia Medication Sales Value by Type (%), 2023 VS 2030
Figure 41. United States Insomnia Medication Sales Value by Application (%), 2023 VS 2030
Figure 42. Europe Insomnia Medication Sales Value, (2019-2030) & (US$ Million)
Figure 43. Europe Insomnia Medication Sales Value by Type (%), 2023 VS 2030
Figure 44. Europe Insomnia Medication Sales Value by Application (%), 2023 VS 2030
Figure 45. China Insomnia Medication Sales Value, (2019-2030) & (US$ Million)
Figure 46. China Insomnia Medication Sales Value by Type (%), 2023 VS 2030
Figure 47. China Insomnia Medication Sales Value by Application (%), 2023 VS 2030
Figure 48. Japan Insomnia Medication Sales Value, (2019-2030) & (US$ Million)
Figure 49. Japan Insomnia Medication Sales Value by Type (%), 2023 VS 2030
Figure 50. Japan Insomnia Medication Sales Value by Application (%), 2023 VS 2030
Figure 51. South Korea Insomnia Medication Sales Value, (2019-2030) & (US$ Million)
Figure 52. South Korea Insomnia Medication Sales Value by Type (%), 2023 VS 2030
Figure 53. South Korea Insomnia Medication Sales Value by Application (%), 2023 VS 2030
Figure 54. Southeast Asia Insomnia Medication Sales Value, (2019-2030) & (US$ Million)
Figure 55. Southeast Asia Insomnia Medication Sales Value by Type (%), 2023 VS 2030
Figure 56. Southeast Asia Insomnia Medication Sales Value by Application (%), 2023 VS 2030
Figure 57. India Insomnia Medication Sales Value, (2019-2030) & (US$ Million)
Figure 58. India Insomnia Medication Sales Value by Type (%), 2023 VS 2030
Figure 59. India Insomnia Medication Sales Value by Application (%), 2023 VS 2030
Figure 60. Insomnia Medication Industrial Chain
Figure 61. Insomnia Medication Manufacturing Cost Structure
Figure 62. Channels of Distribution (Direct Sales, and Distribution)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
DigitalBroadcast and Cinematography Cameras Lease - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Sep 18, 24
Mobile and Web Event Analytics - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Sep 18, 24
Business Information - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Sep 18, 24
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232